Literature DB >> 9310929

Hepatitis B virus genomic heterogeneity: variation between quasispecies may confound molecular epidemiological analyses of transmission incidents.

S L Ngui1, C G Teo.   

Abstract

Nucleotide sequence variability studies were conducted on a 263-base pair fragment of the core-coding genomic region of hepatitis B virus (HBV), amplified by the polymerase chain reaction (PCR) from three surgeons with varying circulating levels of HBV, all of whom were thought to have transmitted HBV to their patients post-surgically. DNA sequencing was applied to amplicons obtained directly from serum and those cloned into plasmid vectors, and from single HBV molecules in serum separated by a limiting dilution procedure. In one surgeon, who had a titre of approximately 3 x 10(5) genome equivalents ml-1, the direct sequence was identical to none of 29 other sequences and differed by one base substitution from the sequence amplified from the single patient he infected. In another surgeon, who had a titre of approximately 2 x 10(6) genome equivalents ml-1, the direct sequence was identical to 17 of 36 (47%) sequences; however, the sequence common to all three infected patients was identical to a unique sequence in the surgeon that differed by three base substitutions from the direct sequence. By contrast, the direct sequence in the third surgeon, who had a titre of approximately 4 x 10(7) genome equivalents ml-1, was identical to 25 of 38 (66%) sequences, and to the sequence common to all 11 infected patients. Assessment of HBV DNA sequences directly amplified from clinical specimens may not be appropriate to studies of transmission in which the source of infection harbours a relatively dilute, heterogeneous mix of viral variants.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9310929     DOI: 10.1046/j.1365-2893.1997.00066.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  7 in total

1.  A novel stop codon mutation in HBsAg gene identified in a hepatitis B virus strain associated with cryptogenic cirrhosis.

Authors:  Xu Yang; Xiao-Peng Tang; Jian-Hua Lei; Hong-Yu Luo; Yong-Hong Zhang
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

Review 2.  Hepatitis B virus genotypes and variants.

Authors:  Chih-Lin Lin; Jia-Horng Kao
Journal:  Cold Spring Harb Perspect Med       Date:  2015-05-01       Impact factor: 6.915

3.  Universal Primers for Detection and Sequencing of Hepatitis B Virus Genomes across Genotypes A to G.

Authors:  Jack Bee Chook; Woon Li Teo; Yun Fong Ngeow; Kok Keng Tee; Kee Peng Ng; Rosmawati Mohamed
Journal:  J Clin Microbiol       Date:  2015-03-18       Impact factor: 5.948

4.  Characterization of Full-Length Genomes of Hepatitis B Virus Quasispecies in Sera of Patients at Different Phases of Infection.

Authors:  Zhi-Tao Yang; Su-Yuan Huang; Li Chen; Feng Liu; Xiao-Hui Cai; Yang-Fan Guo; Ming-Jie Wang; Yue Han; De-Min Yu; Jie-Hong Jiang; Dong-Hua Zhang; Qi-Ming Gong; Guo-Qing Zhang; Guo-Qing Zang; Zhong-Hua Lu; Li-Hua Huang; Xin-Xin Zhang
Journal:  J Clin Microbiol       Date:  2015-04-29       Impact factor: 5.948

5.  Dynamics of hepatitis B virus quasispecies in association with nucleos(t)ide analogue treatment determined by ultra-deep sequencing.

Authors:  Norihiro Nishijima; Hiroyuki Marusawa; Yoshihide Ueda; Ken Takahashi; Akihiro Nasu; Yukio Osaki; Tadayuki Kou; Shujiro Yazumi; Takeshi Fujiwara; Soken Tsuchiya; Kazuharu Shimizu; Shinji Uemoto; Tsutomu Chiba
Journal:  PLoS One       Date:  2012-04-16       Impact factor: 3.240

6.  Characteristics of CpG Islands and their quasispecies of full-length hepatitis B virus genomes from patients at different phases of infection.

Authors:  Yuan Xue; Ming-Jie Wang; Su-Yuan Huang; Zhi-Tao Yang; De-Min Yu; Yue Han; Ming-Yu Zhu; Dao Huang; Dong-Hua Zhang; Qi-Ming Gong; Xin-Xin Zhang
Journal:  Springerplus       Date:  2016-09-21

7.  Universal primers for HBV genome DNA amplification across subtypes: a case study for designing more effective viral primers.

Authors:  Qingrun Zhang; Guanghua Wu; Elliott Richards; Shan'gang Jia; Changqing Zeng
Journal:  Virol J       Date:  2007-09-24       Impact factor: 4.099

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.